39 results
Page 2 of 2
8-K
EX-99.2
ukvjg v35
13 Oct 20
Gossamer Bio Announces Topline Results for Phase 2 Trials of Oral GB001 in Asthma and Chronic Rhinosinusitis
7:40am
8-K
EX-99.1
wltfi47n 4y5eq
24 Mar 20
Gossamer Bio Announces Fourth Quarter and Full-Year 2019 Financial Results and Provides Business Update
8:45am
10-Q
lxxykn4lousn v8q95r
14 May 19
Quarterly report
7:47am
DEF 14A
x6n2u
30 Apr 19
Definitive proxy
4:04pm
10-K
lko9yp 1t
22 Mar 19
Annual report
4:45pm
424B4
q2io936 xxs73nr
8 Feb 19
Prospectus supplement with pricing info
4:40pm
S-1/A
d5gtmx7
23 Jan 19
IPO registration (amended)
4:39pm
S-1/A
EX-10.5
gl1tudwgzdburx
23 Jan 19
IPO registration (amended)
4:39pm
S-1
byc5jmkk86e05cw
21 Dec 18
IPO registration
4:39pm
S-1
EX-10.5
h04m2s tnietk
21 Dec 18
IPO registration
4:39pm
DRS/A
789vnxxsdnq4n4ebb
29 Nov 18
Draft registration statement (amended)
12:00am
DRS
g7dnn91q
11 Oct 18
Draft registration statement
12:00am